Eli Lilly & Co. closed 13.93% short of its 52-week high of $972.53, which the company reached on August 22nd.

Shares of Eli Lilly & Co. LLY slid 4.73% to $869.58 Friday, on what proved to be an all-around positive trading session for ...

Eli Lilly (LLY) concluded the recent trading session at $822.51, signifying a -0.27% move from its prior day's close.

Eli Lilly Chief Executive David Ricks annual compensation rose to $29.2 million in 2024, a 10% increase from the $26.2 million he received a year earlier. Ricks' payout included $19.7 million in ...

"Eli Lilly Introduces New Weight Loss Drug Doses, Lowers Price Points," at 7:36 a.m. incorrectly said Zepbound also comes in 10 and 12.5 milligram vials. We sell different types of products and ...

Eli Lilly (LLY) has launched its weight-loss and diabetes drug, Mounjaro (tirzepatide), in India, securing a first-mover ...

Dow Jones futures tumbled 400 points as tariff concerns resurfaced. Nvidia stock and Tesla sold off on the stock market today.

Dow Jones futures fell slightly Wednesday morning ... Dow giant Caterpillar fell on an earnings miss, while S&P 500 play Eli Lilly tumbled. But techs rose as Google-parent Alphabet jumped more ...

In the most recent trading session, Eli Lilly (LLY) closed at $822.27, indicating a -0.22% shift from the previous trading day.

16:22 EST Eli Lilly (LLY) files automatic mixed securities shelf See what stocks are receiving strong buy ratings from top-rated analysts. Filter, analyze, and streamline your search for investmen ...

Eli Lilly LLY-0.27%decrease; red down pointing triangle is expanding its offerings of its hit weight-loss drug Zepbound for people who want to pay cash instead of using their health plans ...